Ibezapolstat Takes Center Stagehttps://www.marketwatch.com/press-release/acurx-pharmaceuticals-ibezapolstat-takes-center-stage-after-summit-therapeutics-misses-phase-3-cdiff-trial-endpoints-nasdaq-acxp-2022-01-03
Acurx Pharmaceuticals’ Ibezapolstat Takes Center Stage After Summit Therapeutics Misses Phase 3 C.Diff Trial Endpoints (NASDAQ: ACXP)